Name: China's Commercial Health Insurance (Routledge Studies on the Chinese Economy) (en Inglés)
Price: 160431.00 COP
Availability: InStock
Author: China Development Research Foundation
ISBN: 9781032335971

portada China's Commercial Health Insurance (Routledge Studies on the Chinese Economy) (en Inglés)

Formato

Libro Físico

Editorial

Routledge

Autor

China Development Research Foundation

Idioma

Inglés

N° páginas

516

Encuadernación

Tapa Blanda

ISBN13

9781032335971

N° edición

China's Commercial Health Insurance (Routledge Studies on the Chinese Economy) (en Inglés)

China Development Research Foundation (Autor) · Routledge · Tapa Blanda

Libro Nuevo

$ 160.431

$ 267.385

Ahorras: $ 106.954

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 02 de Julio y el Jueves 18 de Julio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "China's Commercial Health Insurance (Routledge Studies on the Chinese Economy) (en Inglés)"

This book examines the financing of China's health system, argues that present arrangements are not adequate and proposes an increased role for commercial health insurance as a way of overcoming the difficulties. Highlighting that China's present social medical insurance system can only cover basic medical services, with the results that many Chinese people with higher income are going abroad for high-quality medical services and that doctors are not bringing in the salaries and obtaining the social status they expect, the book suggests that commercial health insurance offers a possible solution, in that it can help meet the demand of higher-income groups for better healthcare services while at the same time increasing the income of more competent medical professionals. The book goes on to consider the current state of China's commercial insurance industry, outlining the various challenges that the industry needs to overcome if it is to fulfil an increased role, challenges such as greater specialization, increased capacity, structural reform, improved regulation and closer integration with China's medical reform programme.